Red Tortoise LLC’s Avidity Biosciences RNAM Stock Holding History

Red Tortoise LLC’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-123	Closed	-$1.36K	–	580
2023 Q2	$1.36K	Buy	+123	New	+$1.54K	﹤0.01%	518

Other funds holding RNAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Red Tortoise LLC's RNAM Position: Q3 2023 in Review

Red Tortoise LLC sold out of Avidity Biosciences (RNAM) in Q3 2023, closing a stake of 123 shares — an estimated $1.36K sold.

Red Tortoise LLC first reported a position in RNAM in Q2 2023 and held it in 1 quarter. The position peaked at $1.36K in Q2 2023. 142 funds tracked by Wall St. Rank hold RNAM as of Q3 2023.

Red Tortoise LLC reported no remaining Avidity Biosciences position as of Q3 2023 after selling out during the quarter.
Red Tortoise LLC sold 123 Avidity Biosciences shares in Q3 2023, an estimated $1.36K.
Red Tortoise LLC first reported a position in Avidity Biosciences in Q2 2023 and held it in 1 quarter.
Red Tortoise LLC's Avidity Biosciences position peaked at $1.36K in Q2 2023.
142 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2023.

Based on Red Tortoise LLC's 13F filing for Q3 2023, filed 2 Nov 2023.